vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
ASCENT INDUSTRIES CO. is the larger business by last-quarter revenue ($11.9M vs $8.6M, roughly 1.4× Sunshine Biopharma Inc.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -25.0%, a 16.2% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs -10.6%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-1.6M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -34.9%).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
ACNT vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $8.6M |
| Net Profit | $-1.0M | $-2.1M |
| Gross Margin | 14.6% | 35.3% |
| Operating Margin | -21.0% | -20.9% |
| Net Margin | -8.8% | -25.0% |
| Revenue YoY | 13.3% | -10.6% |
| Net Profit YoY | -1.2% | 0.8% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | $8.6M | ||
| Q3 25 | $19.7M | $9.4M | ||
| Q2 25 | $18.7M | $9.4M | ||
| Q1 25 | $24.7M | $8.9M | ||
| Q4 24 | $10.5M | $9.6M | ||
| Q3 24 | $20.9M | $8.4M | ||
| Q2 24 | $21.5M | $9.3M | ||
| Q1 24 | $28.0M | $7.5M |
| Q4 25 | $-1.0M | $-2.1M | ||
| Q3 25 | $-2.1M | $-883.8K | ||
| Q2 25 | $6.3M | $-1.8M | ||
| Q1 25 | $-2.3M | $-1.2M | ||
| Q4 24 | $-1.0M | $-2.2M | ||
| Q3 24 | $-6.2M | $-1.2M | ||
| Q2 24 | $-926.0K | $-494.3K | ||
| Q1 24 | $-5.5M | $-1.3M |
| Q4 25 | 14.6% | 35.3% | ||
| Q3 25 | 29.7% | 32.6% | ||
| Q2 25 | 26.1% | 36.4% | ||
| Q1 25 | 19.3% | 30.7% | ||
| Q4 24 | 24.3% | 32.2% | ||
| Q3 24 | 14.4% | 34.0% | ||
| Q2 24 | 13.1% | 25.3% | ||
| Q1 24 | 8.3% | 31.2% |
| Q4 25 | -21.0% | -20.9% | ||
| Q3 25 | -4.1% | -11.5% | ||
| Q2 25 | -14.4% | -21.8% | ||
| Q1 25 | -4.2% | -14.6% | ||
| Q4 24 | -25.4% | -21.7% | ||
| Q3 24 | -9.4% | -13.1% | ||
| Q2 24 | -8.6% | -13.6% | ||
| Q1 24 | -15.5% | -17.9% |
| Q4 25 | -8.8% | -25.0% | ||
| Q3 25 | -10.6% | -9.4% | ||
| Q2 25 | 33.7% | -18.8% | ||
| Q1 25 | -9.3% | -13.3% | ||
| Q4 24 | -9.8% | -22.5% | ||
| Q3 24 | -29.5% | -14.2% | ||
| Q2 24 | -4.3% | -5.3% | ||
| Q1 24 | -19.7% | -17.0% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.22 | $-0.54 | ||
| Q2 25 | $0.65 | $-0.82 | ||
| Q1 25 | $-0.23 | $-0.44 | ||
| Q4 24 | $-0.11 | $49.77 | ||
| Q3 24 | $-0.61 | $-11.61 | ||
| Q2 24 | $-0.09 | $-43.48 | ||
| Q1 24 | $-0.54 | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.0M | $23.0M |
| Total Assets | $111.9M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | — | ||
| Q3 25 | $58.0M | — | ||
| Q2 25 | $60.5M | — | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $1.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.0M | $23.0M | ||
| Q3 25 | $87.1M | $24.2M | ||
| Q2 25 | $89.7M | $25.7M | ||
| Q1 25 | $91.2M | $22.7M | ||
| Q4 24 | $93.5M | $23.5M | ||
| Q3 24 | $94.7M | $25.0M | ||
| Q2 24 | $101.0M | $23.5M | ||
| Q1 24 | $102.0M | $24.8M |
| Q4 25 | $111.9M | $30.1M | ||
| Q3 25 | $119.9M | $31.5M | ||
| Q2 25 | $122.6M | $32.0M | ||
| Q1 25 | $152.5M | $29.2M | ||
| Q4 24 | $147.3M | $30.6M | ||
| Q3 24 | $148.6M | $30.1M | ||
| Q2 24 | $158.2M | $29.3M | ||
| Q1 24 | $161.0M | $31.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $-1.6M |
| Free Cash FlowOCF − Capex | $-196.0K | $-1.6M |
| FCF MarginFCF / Revenue | -1.7% | -18.9% |
| Capex IntensityCapex / Revenue | 3.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | $-1.6M | ||
| Q3 25 | $1.3M | $-727.8K | ||
| Q2 25 | $-1.4M | $-1.3M | ||
| Q1 25 | $-700.0K | $-1.7M | ||
| Q4 24 | $8.8M | $-3.4M | ||
| Q3 24 | $3.4M | $-1.4M | ||
| Q2 24 | $2.2M | $-4.6M | ||
| Q1 24 | $263.0K | $-3.2M |
| Q4 25 | $-196.0K | $-1.6M | ||
| Q3 25 | $695.0K | $-735.8K | ||
| Q2 25 | $-1.5M | $-1.4M | ||
| Q1 25 | $-1.0M | $-1.7M | ||
| Q4 24 | $8.4M | $-3.5M | ||
| Q3 24 | $3.1M | $-1.9M | ||
| Q2 24 | $1.9M | $-5.6M | ||
| Q1 24 | $25.0K | $-3.2M |
| Q4 25 | -1.7% | -18.9% | ||
| Q3 25 | 3.5% | -7.8% | ||
| Q2 25 | -8.3% | -15.2% | ||
| Q1 25 | -4.1% | -19.3% | ||
| Q4 24 | 80.6% | -36.6% | ||
| Q3 24 | 15.1% | -22.2% | ||
| Q2 24 | 9.1% | -59.7% | ||
| Q1 24 | 0.1% | -43.1% |
| Q4 25 | 3.9% | 0.0% | ||
| Q3 25 | 3.1% | 0.1% | ||
| Q2 25 | 0.8% | 1.7% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 3.7% | 1.1% | ||
| Q3 24 | 1.3% | 6.1% | ||
| Q2 24 | 1.0% | 10.5% | ||
| Q1 24 | 0.9% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
SBFM
Segment breakdown not available.
